长风药业股份有限公司（02652）于2026年2月11日更新翌日披露报表，公告显示公司当日回购14,000股H股，占回购前已发行股本（不包括库存股）约0.0046%。本次回购价格区间在每股35.08港元至35.60港元之间，总额约49.27万港元。
\n\n回购完成后，公司已发行股份总数维持302,223,586股不变，其中已发行股份（不包括库存股份）降至301,985,586股，库存股份增至238,000股。公告提及，回购授权于2025年12月16日获得通过，公司可回购的授权总数为30,222,358股，目前累计已回购238,000股，占授权通过当日已发行股本约0.0787%。
\n\n公司确认本次回购符合香港联交所上市规则及相关法规要求。公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.